{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T21:49:48Z","timestamp":1770328188844,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.humpath.2023.02.002","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T05:23:26Z","timestamp":1676525006000},"page":"1-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions\u2014a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9915-2594","authenticated-orcid":false,"given":"Hardeep Singh","family":"Mudhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana","family":"Milman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tejal","family":"Magan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin M.","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umiya","family":"Harley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Lally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2023.02.002_bib1","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct set of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Eng J Med"},{"key":"10.1016\/j.humpath.2023.02.002_bib2","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/PAS.0b013e3181a1ef36","article-title":"Fluorescence in situ hybridisation (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma","volume":"33","author":"Gerami","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.02.002_bib3","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.5858\/arpa.2011-0673-OA","article-title":"Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions","volume":"136","author":"Zembowicz","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2023.02.002_bib4","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/PAS.0b013e31824b1efd","article-title":"Specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms","volume":"36","author":"Gerami","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.02.002_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-0560.2011.01675.x","article-title":"Editorial: Fillet of FISH","volume":"38","author":"McCalmont","year":"2011","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.02.002_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-0560.2009.01488.x","article-title":"Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridisation","volume":"37","author":"Busam","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.02.002_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/bjophthalmol-2012-302261","article-title":"Fluorescence in situ hybridisation (FISH) in histologically challenging conjunctival melanocytic lesions","volume":"97","author":"Mudhar","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.humpath.2023.02.002_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.humpath.2020.07.020","article-title":"Conjunctival nevi and melanoma: multiparametric immunohistochemical analysis, including p16, SOX10, HMB45, and Ki-67","volume":"103","author":"Milman","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.02.002_bib9","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/s41379-018-0087-6","article-title":"Comparison of melanoma gene expression score with histopathology, fluorescence in situ hybridization, and SNP array for the classification of melanocytic neoplasms","volume":"31","author":"Reimann","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.02.002_bib10","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0000000000001134","article-title":"PRAME expression in melanocytic tumors","volume":"42","author":"Lezcano","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.02.002_bib11","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/cup.14078","article-title":"PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis","volume":"48","author":"LeBlanc","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.02.002_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/his.14452","article-title":"PRAME expression in melanocytic lesions of the conjunctiva","volume":"79","author":"\u0160ekoranja","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2023.02.002_bib13","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/PAS.0000000000001492","article-title":"Comparison of immunohistochemistry for PRAME with cytogenetic test results in the evaluation of challenging melanocytic tumors","volume":"44","author":"Lezcano","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.02.002_bib14","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/DAD.0000000000001951","article-title":"Correlation of FISH and PRAME immunohistochemistry in ambiguous superficial cutaneous melanocytic proliferations","volume":"43","author":"Harvey","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2023.02.002_bib15","series-title":"The AJCC Cancer Staging Manual","article-title":"Conjunctival melanoma","author":"Coupland","year":"2017"},{"key":"10.1016\/j.humpath.2023.02.002_bib16","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.humpath.2023.02.002_bib17","doi-asserted-by":"crossref","DOI":"10.1097\/DAD.0000000000002201","article-title":"PRAME expression in junctional melanocytic proliferations of the conjunctiva: a potential biomarker for primary acquired melanosis\/conjunctival melanocytic intraepithelial lesions","author":"Huang","year":"2022","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2023.02.002_bib18","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.3390\/cancers13153836","article-title":"Definition of biologically distinct groups of conjunctival melanomas according to etiological factors and implications for precision medicine","volume":"13","author":"Gardrat","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2023.02.002_bib19","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/1078-0432.CCR-15-2071","article-title":"PRAME as an independent biomarker for metastasis in uveal melanoma","volume":"22","author":"Field","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2023.02.002_bib20","doi-asserted-by":"crossref","first-page":"59209","DOI":"10.18632\/oncotarget.10962","article-title":"Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas","volume":"7","author":"Field","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2023.02.002_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s43141-022-00376-7","article-title":"Correlation of preferentially expressed antigen of melanoma (PRAME) gene expression with clinical characteristics in acute leukemia patients","volume":"20","author":"Kulkarni","year":"2022","journal-title":"Genet Eng Biotechnol"},{"key":"10.1016\/j.humpath.2023.02.002_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/CJI.0000000000000322","article-title":"WT1, PRAME, and PR3 mRNA expression in acute myeloid leukemia (AML)","volume":"43","author":"Steger","year":"2020","journal-title":"J Immunother"},{"key":"10.1016\/j.humpath.2023.02.002_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7754\/Clin.Lab.2013.121137","article-title":"Abd El Messih HM PRAME gene expression in childhood acute lymphoblastic leukemia: impact on prognosis","volume":"60","author":"Abdelmalak","year":"2014","journal-title":"Clin Lab"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723000308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723000308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:40:29Z","timestamp":1758645629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817723000308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":23,"alternative-id":["S0046817723000308"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2023.02.002","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions\u2014a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2023.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}